Research Topics
| Mx PatelSummaryAffiliation: King's College London Country: UK Publications
| Collaborators
|
Detail Information
Publications
Attitudes regarding mental health nurse prescribing among psychiatrists and nurses: a cross-sectional questionnaire studyM X Patel
Division of Psychological Medicine, Box 68, Institute of Psychiatry, King s College London, De Crespigny Park, London SE5 8AF, UK
Int J Nurs Stud 46:1467-74. 2009..In the United Kingdom, mental health nurses (MHNs) can independently prescribe medication once they have completed a training course. This study investigated attitudes to mental health nurse prescribing held by psychiatrists and nurses...
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 yearsM X Patel
Division of Psychological Medicine, Institute of Psychiatry, King s College London, London, UK
J Psychopharmacol 24:1473-82. 2010..Concerns about patient acceptance continue as do negative views about some aspects of LAI use; these may compromise medication choices offered to patients...
Prognostic indicators for early discontinuation of risperidone long-acting injectionMaxine X Patel
Division of Psychological Medicine, Institute of Psychiatry and GKT School of Medicine, De Crespigny Park, London, UK
Int Clin Psychopharmacol 19:233-9. 2004..RLAI discontinuation is high early on but subsequently tapers off. Preceding antipsychotic type (depot versus oral) is a stronger prognostic indicator than treatment refractoriness for RLAI discontinuation...
Are depot antipsychotics more coercive than tablets? The patient's perspectiveM X Patel
Division of Psychological Medicine, Institute of Psychiatry, King s College London, London, UK
J Psychopharmacol 24:1483-9. 2010..Although forced medication is sometimes required, the experience of coercion should be minimised by giving patients a fair say in treatment decisions, regardless of formulation...
A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oralMaxine X Patel
Division of Psychological Medicine, Institute of Psychiatry, King s College London, Box 68, De Crespigny Park, London SE5 8AF, UK
J Clin Psychiatry 69:1548-56. 2008..The study is novel in also encompassing such factors as injection phobia and perceived coercion regarding medication in relation to self-reported adherence...
Antipsychotic depot medication and attitudes of community psychiatric nursesM X Patel
Division of Psychological Medicine, Institute of Psychiatry and GKT School of Medicine, De Crespigny Park, London, UK
J Psychiatr Ment Health Nurs 12:237-44. 2005..Training/refresher courses about depots should highlight systematic treatment decision-making and side effect monitoring which, in turn, may improve professionals' attitudes, knowledge and clinical monitoring of depots...
Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with LondonM X Patel
Division of Psychological Medicine, Institute of Psychiatry, King s College London, London, UK
J Psychiatr Ment Health Nurs 15:758-66. 2008..001). In conclusion, therefore, international variation exists and encompasses clinical practice aspects for both the patient and the depot formulation per se. Our participants wanted more involvement in treatment decision making...
Depot and oral antipsychotics: patient preferences and attitudes are not the same thingM X Patel
Institute of Psychiatry, Division of Psychological Medicine, London, UK
J Psychopharmacol 23:789-96. 2009..Whatever leads some to switch from depot to oral, leaves a lasting negative impression of the depot and this may limit uptake of newer depots...
Psychiatrists' attitudes to maintenance medication for patients with schizophreniaM X Patel
Division of Psychological Medicine, Institute of Psychiatry, London
Psychol Med 33:83-9. 2003..By updating psychiatrists' knowledge about depots, in turn their attitudes may become more positive and prescribing practices may subsequently change...
Chronic fatigue syndrome in children: a cross sectional surveyM X Patel
Institute of Psychiatry and GKT School of Medicine, De Crespigny Park, London SE5 8AF, UK
Arch Dis Child 88:894-8. 2003..However, the impact of the illness is significant and this is perhaps most evident in terms of education. Current methods of reporting educational outcomes in the literature are varied and merit development of standardised tools...
Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcomeDavid M Taylor
Pharmacy Department, Maudsley Hospital, London, UK
Int J Neuropsychopharmacol 9:685-94. 2006..61, p=0.001). Overall outcome of RLAI treatment is moderately good but better still when prescribed because of prior poor adherence and for more elderly patients. RLAI is less suitable for those who have previously received clozapine...
Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patientsDavid M Taylor
Pharmacy Department, Maudsley Hospital, London, United Kingdom
J Clin Psychiatry 65:1076-83. 2004..The use of risperidone long-acting injection (RLAI) is reasonably well supported by controlled studies. Little is known about treatment outcomes in patients receiving RLAI in clinical practice...
The effect of long-acting risperidone on working memory in schizophrenia: a functional magnetic resonance imaging studySimon A Surguladze
Department of Psychiatry, King s College London Institute of Psychiatry, De Crespigny Park, London, UK
J Clin Psychopharmacol 27:560-70. 2007..We conclude that RLAI may contribute to normalization of brain activation in regions involved in working memory functioning in people with chronic schizophrenia...
Attitudes to psychosis: health professionalsMaxine X Patel
Epidemiol Psichiatr Soc 13:213-8. 2004
